Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatic Disorder”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT02975323
What this trial is testing

Doppler Ultrasound Hepatic Vein Waveform as a Non-invasive Tool in the Assessment of Severity of Portal Hypertension

Who this might be right for
Portal Hypertension
Aga Khan University 50
Post-approval studies (Phase 4)UnknownNCT04326803
What this trial is testing

Hepatitis B en Haitian Immigrants in Chile: Molecular Characterization and Determination of Vaccine Response

Who this might be right for
Hepatitis B
Pontificia Universidad Catolica de Chile 200
Not applicableStudy completedNCT00782886
What this trial is testing

Evaluation of Image-Guided Liver Surgical System for Resection of Liver Cancer

Who this might be right for
Liver Cancer
Pathfinder Therapeutics 75
Early research (Phase 1)UnknownNCT05643417
What this trial is testing

Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy

Who this might be right for
Metastatic Liver Cancer
Fudan University 80
Not applicableLooking for participantsNCT07715617
What this trial is testing

Development of a Prediction Score for the Occurrence of Death or Lung Transplantation in Patients With Emphysema Secondary to Alpha-1-anti-tripsin Deficiency

Who this might be right for
Alpha-1-antitrypsin DeficiencyEmphysemaArtificial Intelligence (AI)+3 more
University Hospital, Bordeaux 230
Post-approval studies (Phase 4)UnknownNCT01337440
What this trial is testing

Efficacy and Safety of Ursodeoxycholic Acid (UDCA) Added to the DPP-4 Inhibitor in People With Type 2 Diabetes and Chronic Liver Diseases

Who this might be right for
Type 2 Diabetes MellitusChronic Liver Disease
Kanazawa University 20
Testing effectiveness (Phase 2)Study completedNCT05623189
What this trial is testing

HTD1801 in Adults With Nonalcoholic Steatohepatitis and Liver Fibrosis Who Have Type 2 Diabetes or Pre-Diabetes

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Type 2 Diabetes
HighTide Therapeutics (Hong Kong) Limited 218
Not applicableStudy completedNCT04046718
What this trial is testing

Lipid Profile Response to Electroacupuncture Stimulation in Non Alcoholic Fatty Liver Patients

Who this might be right for
Fatty Liver , Electroacupuncture, Lipid Profile
Ramy Salama Draz 60
Early research (Phase 1)Study completedNCT06390410
What this trial is testing

A Pharmacokinetic Study of Simufilam in Subjects With Impaired Hepatic Function

Who this might be right for
Hepatic Insufficiency
Cassava Sciences, Inc. 27
Early research (Phase 1)Study completedNCT00370513
What this trial is testing

A Phase I Study of Pazopanib in Adult Patients With Liver Cancer

Who this might be right for
Carcinoma, Hepatocellular
GlaxoSmithKline 28
Not applicableLooking for participantsNCT06881082
What this trial is testing

Cross-section Band Ligation Versus Stepladder Band Ligation of Esophageal Varices

Who this might be right for
Esophageal Varices
Tanta University 320
Not applicableUnknownNCT05573282
What this trial is testing

Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 50
Post-approval studies (Phase 4)UnknownNCT01724723
What this trial is testing

Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment

Who this might be right for
HepatitisTuberculosishepatitisB
National Taiwan University Hospital 50
Post-approval studies (Phase 4)Study completedNCT00687180
What this trial is testing

Mycophenolate vs Azathioprin in Autoimmune Hepatitis

Who this might be right for
Autoimmune Hepatitis
Rigshospitalet, Denmark
Testing effectiveness (Phase 2)WithdrawnNCT06902246
What this trial is testing

Regorafenib and Yttrium-90 Radioembolization for Unresectable Hepatocellular Carcinoma

Who this might be right for
Unresectable Hepatocellular CarcinomaHepatocellular Carcinoma
University of Miami
Large-scale testing (Phase 3)Study completedNCT00114361
What this trial is testing

48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection

Who this might be right for
Hepatitis B
Foundation for Liver Research 138
Early research (Phase 1)Study completedNCT01371162
What this trial is testing

RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic, Healthy Volunteer
Hoffmann-La Roche 42
Testing effectiveness (Phase 2)WithdrawnNCT03307603
What this trial is testing

Yttrium-90 Radioembolization + Nivolumab for Liver + Extra-hepatic Metastases From Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Case Comprehensive Cancer Center
Not applicableStudy completedNCT01904942
What this trial is testing

Study of Hepatocellular Carcinoma in Cirrhotic Patients

Who this might be right for
Hepatocellular Carcinoma
Centre Hospitalier Universitaire Dijon 600
Not applicableUnknownNCT03648086
What this trial is testing

Intestinal Microbiota Transplantation for Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic Fatty Liver Disease
Zhongshan Hospital Xiamen University 30
Next Page